Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: health – Page 158

Vaccine for Bee Venom Allergy

Stinging of Hymenoptera can induce IgE-mediated hypersensitivity reactions in patients with venom allergies, ranging from local to severe systemic reactions and even fatal anaphylaxis. Allergic patients’ quality of life can be primarily improved by injecting increased venom doses to alter their immune response to tolerate venom. This venom-specific immunotherapy is very effective and well tolerated, especially in the administration of vaccines. Creative Biolabs is a world leader in the field of vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best vaccine development services for allergic disease.

Creative Biolabs provides vaccine development services for bee venom allergy according to customer’s detailed requirements.

Exercise can increase the number of immune cells in the bloodstream of cancer patients

Exercise decreases the risk of cancer and reduces side effects of cancer treatments. In addition, it improves patients’ quality of life and the prognosis of cancer patients. This is according to two new Finnish studies.

“It was previously thought that cancer patients should just rest after a . Today, we have more and more researched information that can even improve the prognosis of cancer. However, it is not yet fully known how exercise controls cancer,” explains Research Assistant Tiia Koivula.

Previous preclinical studies have found that exercise affects the functioning of the immune system so that more are transferred to the tumor site and they become more active in destroying . Two studies conducted at the Turku PET Center of the University of Turku in Finland aimed to find out whether a short exercise bout affects the mobilization of immune cells in cancer patients.

AI Weekly: AI Leaders At White House, OpenAI Adds $300 Million, Empathetic Pi Chatbot Launches

Some of the big AI tech companies (Google, Microsoft, OpenAI, and Anthropic) sat with Vice-President Kamala Harris for two hours on Thursday. President Biden stopped by the meeting, telling the execs “What you’re doing has enormous potential and enormous danger.” An “independent exercise” at DEF CON 31, a major hacker event in August, will provide a transparent public assessments of how well existing generative AI systems meet the Biden administration’s AI Bill of Rights blueprint.

Is it possible to get ahead of unintended consequences?

Dr Erwin Gianchandani — Assistant Director for Technology, Innovation and Partnerships, U.S. NSF

Accelerating Breakthroughs in Critical and Emerging Technologies — Dr. Erwin Gianchandani, Ph.D. — Assistant Director for Technology, Innovation and Partnerships, U.S. National Science Foundation (NSF)

Dr. Erwin Gianchandani, Ph.D. is Assistant Director for Technology, Innovation and Partnerships, U.S. National Science Foundation, leading the newly established TIP Directorate (https://new.nsf.gov/tip/leadership).

The TIP Directorate is focused on harnessing the nation’s vast and diverse talent pool to advance critical and emerging technologies, addressing pressing societal and economic challenges, and accelerating the translation of research results from lab to market and society, ultimately improving U.S. competitiveness, growing the U.S. economy and training a diverse workforce for future, high-wage jobs.

Prior to becoming the Assistant Director for TIP, Dr. Gianchandani served as the senior advisor for Translation, Innovation and Partnerships, where he helped develop plans for the new TIP Directorate in collaboration with colleagues at NSF, other government agencies, industry, and academia.

During the previous six years, Dr. Gianchandani was the NSF deputy assistant director for Computer and Information Science and Engineering (CISE), twice serving as acting assistant director. His leadership and management of CISE included the formulation and implementation of the directorate’s $1 billion annual budget, strategic and human capital planning, and oversight of day-to-day operations for a team of over 130.

Continue reading “Dr Erwin Gianchandani — Assistant Director for Technology, Innovation and Partnerships, U.S. NSF” | >

A new nondestructive method for assessing bioengineered artificial tissues

Engineering organs to replace damaged hearts or kidneys in the human body may seem like something out of a sci-fi movie, but the building blocks for this technology are already in place. In the burgeoning field of tissue engineering, live cells grow in artificial scaffolds to form biological tissue. But to evaluate how successfully the cells develop into tissue, researchers need a reliable method to monitor the cells as they move and multiply.

Now, scientists at the National Institute of Standards and Technology (NIST), the U.S Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have developed a noninvasive method to count the in a three-dimensional (3D) . The real-time technique images millimeter-scale regions to assess the viability of the cells and how the cells are distributed within the scaffold—an important capability for researchers who manufacture complex biological tissues from simple materials such as living cells.

Their findings have been published in the Journal of Biomedical Materials Research Part A.

AI could run a million microbial experiments per year, says study

An artificial intelligence system enables robots to conduct autonomous scientific experiments—as many as 10,000 per day—potentially driving a drastic leap forward in the pace of discovery in areas from medicine to agriculture to environmental science.

Reported today in Nature Microbiology, the research was led by a professor now at the University of Michigan.

That , dubbed BacterAI, mapped the metabolism of two associated with —with no baseline information to start with. Bacteria consume some combination of the 20 amino acids needed to support life, but each species requires specific nutrients to grow. The U-M team wanted to know what amino acids are needed by the beneficial microbes in our mouths so they can promote their growth.

Case report: Magic mushrooms may induce lasting improvements in color-blind vision

Researchers at the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute at the Cleveland Clinic in Ohio have authored a case report on the positive effects of psilocybin on color blindness.

Published in the journal Drug Science, Policy and Law, the researchers highlight some implications surrounding a single reported vision improvement self-study by a colleague and cite other previous reports, illustrating a need to understand better how these psychedelics could be used in therapeutic settings.

Past reports have indicated that people with deficiency (CVD), usually referred to as , experience better color vision after using lysergic acid diethylamide (LSD) or psilocybin (magic mushrooms). There is a lack of scientific evidence for these claims, as researching the effects of these drugs has been highly restricted.

New Indigo Light Kills Bacteria at Hospitals

Year 2015 😗😁

Indigo-Clean is a new light that is capable of killing bacteria. Used in a healthcare settings, the device could help prevent the spread of dangerous microorganisms, including Methicillin-resistant Staphylococcus aureus (MRSA), a bacterium responsible for several difficult-to-treat infections in humans.

Bacteria in the air absorb the indigo-colored light, which then creates a chemical reaction within the microorganism. This creates an environment that acts like bleach, killing the microscopic lifeform, reports Tech Times.

The new bacteria-killing light was introduced to the public at an annual meeting of the Association for Professionals in Infection Control and Epidemiology. The device was first constructed in 2008 and has undergone real-world testing at the University of Strathclyde in Glasgow. Health professionals have noted the effectiveness of the light at killing bacteria that could otherwise spread to patients.

Study offers fresh hope for people living with chronic back pain

Long-term sufferers of chronic back pain experienced dramatic reductions in pain and related disability that remained at their one-year follow-up after taking part in a new treatment tested by Curtin-Macquarie-Monash University research.

Published today in the journal The Lancet, the research found large clinically significant improvements in the intensity of pain and pain-related disability among almost 500 people who had been seeking help for their pain for an average of four years before trialing the new treatment.

The treatment, which delivered a health care and work productivity saving of more than $5,000 per person, took a whole-person approach by also helping people to make lifestyle changes aimed at improving their social and emotional health.

PrivateGPT Tackles Sensitive Info in ChatGPT Prompts

Amidst concerns that employees could be entering sensitive information into the ChatGPT artificial intelligence model, a data privacy vendor has launched a redaction tool aimed at reducing companies’ risk from inadvertently exposing customer and employee data.

Private AI’s new PrivateGPT platform integrates with OpenAI’s high-profile chatbot, automatically redacting 50+ types of personally identifiable information (PII) in real time as users enter ChatGPT prompts.

PrivateGPT sits in the middle of the chat process, stripping out everything from health data and credit-card information to contact data, dates of birth, and Social Security numbers from user prompts, before sending them through to ChatGPT. When ChatGPT responds, PrivateGPT re-populates the PII within the answer, to make the experience more seamless for users, according to a statement this week from PrivateGPT creator Private AI.